nodes	percent_of_prediction	percent_of_DWPC	metapath
Zoledronate—Reaction gastrointestinal—Metformin—polycystic ovary syndrome	0.0298	0.0785	CcSEcCtD
Zoledronate—GGPS1—adrenal cortex—polycystic ovary syndrome	0.029	0.0702	CbGeAlD
Zoledronate—GGPS1—endometrium—polycystic ovary syndrome	0.0259	0.0627	CbGeAlD
Zoledronate—GGPS1—uterus—polycystic ovary syndrome	0.0238	0.0577	CbGeAlD
Zoledronate—GGPS1—pituitary gland—polycystic ovary syndrome	0.0234	0.0567	CbGeAlD
Zoledronate—GGPS1—adipose tissue—polycystic ovary syndrome	0.0233	0.0565	CbGeAlD
Zoledronate—GGPS1—adrenal gland—polycystic ovary syndrome	0.0209	0.0507	CbGeAlD
Zoledronate—GGPS1—female gonad—polycystic ovary syndrome	0.0195	0.0472	CbGeAlD
Zoledronate—GGPS1—vagina—polycystic ovary syndrome	0.0194	0.0469	CbGeAlD
Zoledronate—Azotaemia—Metformin—polycystic ovary syndrome	0.0187	0.0492	CcSEcCtD
Zoledronate—GGPS1—endocrine gland—polycystic ovary syndrome	0.0181	0.0439	CbGeAlD
Zoledronate—Toothache—Metformin—polycystic ovary syndrome	0.0163	0.0431	CcSEcCtD
Zoledronate—FDPS—adrenal cortex—polycystic ovary syndrome	0.0134	0.0323	CbGeAlD
Zoledronate—CA14—adrenal gland—polycystic ovary syndrome	0.0125	0.0303	CbGeAlD
Zoledronate—Rigors—Metformin—polycystic ovary syndrome	0.0122	0.0321	CcSEcCtD
Zoledronate—FDPS—endometrium—polycystic ovary syndrome	0.0119	0.0289	CbGeAlD
Zoledronate—FDPS—uterus—polycystic ovary syndrome	0.011	0.0266	CbGeAlD
Zoledronate—FDPS—pituitary gland—polycystic ovary syndrome	0.0108	0.0261	CbGeAlD
Zoledronate—FDPS—adipose tissue—polycystic ovary syndrome	0.0108	0.026	CbGeAlD
Zoledronate—FDPS—adrenal gland—polycystic ovary syndrome	0.00964	0.0234	CbGeAlD
Zoledronate—FDPS—female gonad—polycystic ovary syndrome	0.00899	0.0218	CbGeAlD
Zoledronate—FDPS—vagina—polycystic ovary syndrome	0.00894	0.0216	CbGeAlD
Zoledronate—CA2—embryo—polycystic ovary syndrome	0.00846	0.0205	CbGeAlD
Zoledronate—CA12—endocrine gland—polycystic ovary syndrome	0.00846	0.0205	CbGeAlD
Zoledronate—FDPS—endocrine gland—polycystic ovary syndrome	0.00836	0.0202	CbGeAlD
Zoledronate—ABCC1—adrenal cortex—polycystic ovary syndrome	0.00776	0.0188	CbGeAlD
Zoledronate—Renal impairment—Metformin—polycystic ovary syndrome	0.00758	0.02	CcSEcCtD
Zoledronate—Lethargy—Metformin—polycystic ovary syndrome	0.00736	0.0194	CcSEcCtD
Zoledronate—Pain in extremity—Metformin—polycystic ovary syndrome	0.00721	0.019	CcSEcCtD
Zoledronate—CA2—adrenal cortex—polycystic ovary syndrome	0.00694	0.0168	CbGeAlD
Zoledronate—ABCC1—endometrium—polycystic ovary syndrome	0.00693	0.0168	CbGeAlD
Zoledronate—Dehydration—Metformin—polycystic ovary syndrome	0.00671	0.0177	CcSEcCtD
Zoledronate—Abdominal pain upper—Metformin—polycystic ovary syndrome	0.00659	0.0174	CcSEcCtD
Zoledronate—Cramp muscle—Metformin—polycystic ovary syndrome	0.0065	0.0171	CcSEcCtD
Zoledronate—Nasopharyngitis—Metformin—polycystic ovary syndrome	0.00645	0.017	CcSEcCtD
Zoledronate—ABCC1—uterus—polycystic ovary syndrome	0.00638	0.0155	CbGeAlD
Zoledronate—Abdominal distension—Metformin—polycystic ovary syndrome	0.00628	0.0166	CcSEcCtD
Zoledronate—ABCC1—pituitary gland—polycystic ovary syndrome	0.00627	0.0152	CbGeAlD
Zoledronate—ABCC1—adipose tissue—polycystic ovary syndrome	0.00624	0.0151	CbGeAlD
Zoledronate—Influenza—Metformin—polycystic ovary syndrome	0.00623	0.0164	CcSEcCtD
Zoledronate—Sweating increased—Metformin—polycystic ovary syndrome	0.00607	0.016	CcSEcCtD
Zoledronate—Abdominal discomfort—Metformin—polycystic ovary syndrome	0.00598	0.0158	CcSEcCtD
Zoledronate—Neutropenia—Metformin—polycystic ovary syndrome	0.00583	0.0154	CcSEcCtD
Zoledronate—Upper respiratory tract infection—Metformin—polycystic ovary syndrome	0.00579	0.0153	CcSEcCtD
Zoledronate—CA2—pituitary gland—polycystic ovary syndrome	0.0056	0.0136	CbGeAlD
Zoledronate—ABCC1—adrenal gland—polycystic ovary syndrome	0.0056	0.0136	CbGeAlD
Zoledronate—CA2—adipose tissue—polycystic ovary syndrome	0.00558	0.0135	CbGeAlD
Zoledronate—Infestation NOS—Metformin—polycystic ovary syndrome	0.00556	0.0147	CcSEcCtD
Zoledronate—Infestation—Metformin—polycystic ovary syndrome	0.00556	0.0147	CcSEcCtD
Zoledronate—ABCC1—female gonad—polycystic ovary syndrome	0.00522	0.0126	CbGeAlD
Zoledronate—ABCC1—vagina—polycystic ovary syndrome	0.00519	0.0126	CbGeAlD
Zoledronate—Bradycardia—Metformin—polycystic ovary syndrome	0.00508	0.0134	CcSEcCtD
Zoledronate—CA2—adrenal gland—polycystic ovary syndrome	0.00501	0.0121	CbGeAlD
Zoledronate—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.00497	0.0131	CcSEcCtD
Zoledronate—Oedema peripheral—Metformin—polycystic ovary syndrome	0.00492	0.013	CcSEcCtD
Zoledronate—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.0049	0.0129	CcSEcCtD
Zoledronate—CA2—female gonad—polycystic ovary syndrome	0.00467	0.0113	CbGeAlD
Zoledronate—Eye disorder—Metformin—polycystic ovary syndrome	0.00466	0.0123	CcSEcCtD
Zoledronate—CA2—vagina—polycystic ovary syndrome	0.00464	0.0112	CbGeAlD
Zoledronate—Flushing—Metformin—polycystic ovary syndrome	0.00463	0.0122	CcSEcCtD
Zoledronate—Cardiac disorder—Metformin—polycystic ovary syndrome	0.00463	0.0122	CcSEcCtD
Zoledronate—Angiopathy—Metformin—polycystic ovary syndrome	0.00453	0.0119	CcSEcCtD
Zoledronate—Immune system disorder—Metformin—polycystic ovary syndrome	0.00451	0.0119	CcSEcCtD
Zoledronate—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.0045	0.0119	CcSEcCtD
Zoledronate—Chills—Metformin—polycystic ovary syndrome	0.00448	0.0118	CcSEcCtD
Zoledronate—Malnutrition—Metformin—polycystic ovary syndrome	0.00434	0.0115	CcSEcCtD
Zoledronate—Erythema—Metformin—polycystic ovary syndrome	0.00434	0.0115	CcSEcCtD
Zoledronate—CA2—endocrine gland—polycystic ovary syndrome	0.00434	0.0105	CbGeAlD
Zoledronate—Dysgeusia—Metformin—polycystic ovary syndrome	0.00425	0.0112	CcSEcCtD
Zoledronate—Muscle spasms—Metformin—polycystic ovary syndrome	0.00418	0.011	CcSEcCtD
Zoledronate—Vision blurred—Metformin—polycystic ovary syndrome	0.00409	0.0108	CcSEcCtD
Zoledronate—Tremor—Metformin—polycystic ovary syndrome	0.00407	0.0107	CcSEcCtD
Zoledronate—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.00403	0.0106	CcSEcCtD
Zoledronate—Malaise—Metformin—polycystic ovary syndrome	0.00392	0.0103	CcSEcCtD
Zoledronate—Syncope—Metformin—polycystic ovary syndrome	0.0039	0.0103	CcSEcCtD
Zoledronate—Palpitations—Metformin—polycystic ovary syndrome	0.00384	0.0101	CcSEcCtD
Zoledronate—Loss of consciousness—Metformin—polycystic ovary syndrome	0.00382	0.0101	CcSEcCtD
Zoledronate—Hypertension—Metformin—polycystic ovary syndrome	0.00375	0.00989	CcSEcCtD
Zoledronate—Chest pain—Metformin—polycystic ovary syndrome	0.0037	0.00975	CcSEcCtD
Zoledronate—Myalgia—Metformin—polycystic ovary syndrome	0.0037	0.00975	CcSEcCtD
Zoledronate—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.00367	0.00969	CcSEcCtD
Zoledronate—Discomfort—Metformin—polycystic ovary syndrome	0.00365	0.00964	CcSEcCtD
Zoledronate—Oedema—Metformin—polycystic ovary syndrome	0.00355	0.00935	CcSEcCtD
Zoledronate—Infection—Metformin—polycystic ovary syndrome	0.00352	0.00929	CcSEcCtD
Zoledronate—Shock—Metformin—polycystic ovary syndrome	0.00349	0.0092	CcSEcCtD
Zoledronate—Nervous system disorder—Metformin—polycystic ovary syndrome	0.00348	0.00917	CcSEcCtD
Zoledronate—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.00347	0.00916	CcSEcCtD
Zoledronate—Skin disorder—Metformin—polycystic ovary syndrome	0.00344	0.00908	CcSEcCtD
Zoledronate—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.00343	0.00904	CcSEcCtD
Zoledronate—Anorexia—Metformin—polycystic ovary syndrome	0.00338	0.00891	CcSEcCtD
Zoledronate—Hypotension—Metformin—polycystic ovary syndrome	0.00331	0.00874	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.00323	0.00852	CcSEcCtD
Zoledronate—Paraesthesia—Metformin—polycystic ovary syndrome	0.00318	0.0084	CcSEcCtD
Zoledronate—Dyspnoea—Metformin—polycystic ovary syndrome	0.00316	0.00834	CcSEcCtD
Zoledronate—Somnolence—Metformin—polycystic ovary syndrome	0.00315	0.00831	CcSEcCtD
Zoledronate—Dyspepsia—Metformin—polycystic ovary syndrome	0.00312	0.00823	CcSEcCtD
Zoledronate—Decreased appetite—Metformin—polycystic ovary syndrome	0.00308	0.00813	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00306	0.00807	CcSEcCtD
Zoledronate—Fatigue—Metformin—polycystic ovary syndrome	0.00306	0.00806	CcSEcCtD
Zoledronate—Constipation—Metformin—polycystic ovary syndrome	0.00303	0.008	CcSEcCtD
Zoledronate—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00292	0.00771	CcSEcCtD
Zoledronate—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.0029	0.00765	CcSEcCtD
Zoledronate—Urticaria—Metformin—polycystic ovary syndrome	0.00282	0.00743	CcSEcCtD
Zoledronate—Abdominal pain—Metformin—polycystic ovary syndrome	0.0028	0.00739	CcSEcCtD
Zoledronate—Asthenia—Metformin—polycystic ovary syndrome	0.00254	0.00671	CcSEcCtD
Zoledronate—Pruritus—Metformin—polycystic ovary syndrome	0.00251	0.00662	CcSEcCtD
Zoledronate—Diarrhoea—Metformin—polycystic ovary syndrome	0.00243	0.0064	CcSEcCtD
Zoledronate—Dizziness—Metformin—polycystic ovary syndrome	0.00234	0.00618	CcSEcCtD
Zoledronate—Vomiting—Metformin—polycystic ovary syndrome	0.00225	0.00595	CcSEcCtD
Zoledronate—Rash—Metformin—polycystic ovary syndrome	0.00224	0.0059	CcSEcCtD
Zoledronate—Dermatitis—Metformin—polycystic ovary syndrome	0.00223	0.00589	CcSEcCtD
Zoledronate—Headache—Metformin—polycystic ovary syndrome	0.00222	0.00586	CcSEcCtD
Zoledronate—Nausea—Metformin—polycystic ovary syndrome	0.00211	0.00555	CcSEcCtD
Zoledronate—GGPS1—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.0014	0.00673	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.00136	0.00653	CbGpPWpGaD
Zoledronate—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—NAMPT—polycystic ovary syndrome	0.00132	0.00634	CbGpPWpGaD
Zoledronate—CA14—Metabolism—NMNAT3—polycystic ovary syndrome	0.00126	0.00607	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—HMMR—polycystic ovary syndrome	0.00126	0.00607	CbGpPWpGaD
Zoledronate—ABCC1—S1P1 pathway—VEGFA—polycystic ovary syndrome	0.00122	0.00587	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—HSD3B1—polycystic ovary syndrome	0.0012	0.00579	CbGpPWpGaD
Zoledronate—ABCC1—Arachidonic acid metabolism—CYP1A1—polycystic ovary syndrome	0.0012	0.00578	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.00119	0.00572	CbGpPWpGaD
Zoledronate—CA14—Metabolism—SUOX—polycystic ovary syndrome	0.00115	0.00555	CbGpPWpGaD
Zoledronate—CA14—Metabolism—LPCAT2—polycystic ovary syndrome	0.00115	0.00555	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.00115	0.00555	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.00113	0.00542	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—NMNAT3—polycystic ovary syndrome	0.0011	0.0053	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—LHB—polycystic ovary syndrome	0.0011	0.00528	CbGpPWpGaD
Zoledronate—CA14—Metabolism—ISYNA1—polycystic ovary syndrome	0.00107	0.00516	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—HSD3B2—polycystic ovary syndrome	0.00107	0.00516	CbGpPWpGaD
Zoledronate—CA12—Metabolism—NMNAT3—polycystic ovary syndrome	0.00106	0.00511	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.00105	0.00506	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—AKR1C1—polycystic ovary syndrome	0.00104	0.005	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.00103	0.00495	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—LPCAT2—polycystic ovary syndrome	0.00101	0.00485	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—SUOX—polycystic ovary syndrome	0.00101	0.00485	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000996	0.00479	CbGpPWpGaD
Zoledronate—CA12—Metabolism—SUOX—polycystic ovary syndrome	0.000972	0.00468	CbGpPWpGaD
Zoledronate—CA12—Metabolism—LPCAT2—polycystic ovary syndrome	0.000972	0.00468	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—SULT2A1—polycystic ovary syndrome	0.000956	0.0046	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	0.000943	0.00453	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—ISYNA1—polycystic ovary syndrome	0.000937	0.00451	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—RRM2—polycystic ovary syndrome	0.000926	0.00445	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000916	0.00441	CbGpPWpGaD
Zoledronate—CA14—Metabolism—AKR1C2—polycystic ovary syndrome	0.000912	0.00439	CbGpPWpGaD
Zoledronate—CA14—Metabolism—TEAD2—polycystic ovary syndrome	0.000912	0.00439	CbGpPWpGaD
Zoledronate—CA12—Metabolism—ISYNA1—polycystic ovary syndrome	0.000904	0.00435	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—YAP1—polycystic ovary syndrome	0.000892	0.00429	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—NAMPT—polycystic ovary syndrome	0.000857	0.00412	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000855	0.00411	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000852	0.0041	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—CYP11A1—polycystic ovary syndrome	0.000847	0.00407	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000841	0.00404	CbGpPWpGaD
Zoledronate—CA2—Metabolism—NMNAT3—polycystic ovary syndrome	0.000813	0.00391	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000812	0.0039	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.000808	0.00389	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—AKR1C3—polycystic ovary syndrome	0.0008	0.00385	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—AKR1C2—polycystic ovary syndrome	0.000797	0.00383	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—TEAD2—polycystic ovary syndrome	0.000797	0.00383	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—CYP17A1—polycystic ovary syndrome	0.000787	0.00379	CbGpPWpGaD
Zoledronate—CA12—Metabolism—TEAD2—polycystic ovary syndrome	0.000769	0.0037	CbGpPWpGaD
Zoledronate—CA12—Metabolism—AKR1C2—polycystic ovary syndrome	0.000769	0.0037	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000766	0.00369	CbGpPWpGaD
Zoledronate—CA14—Metabolism—PNPLA2—polycystic ovary syndrome	0.000764	0.00368	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000755	0.00363	CbGpPWpGaD
Zoledronate—CA2—Metabolism—LPCAT2—polycystic ovary syndrome	0.000743	0.00358	CbGpPWpGaD
Zoledronate—CA2—Metabolism—SUOX—polycystic ovary syndrome	0.000743	0.00358	CbGpPWpGaD
Zoledronate—CA14—Metabolism—SRD5A1—polycystic ovary syndrome	0.000724	0.00348	CbGpPWpGaD
Zoledronate—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—polycystic ovary syndrome	0.000719	0.00346	CbGpPWpGaD
Zoledronate—CA14—Metabolism—STAR—polycystic ovary syndrome	0.000691	0.00332	CbGpPWpGaD
Zoledronate—CA2—Metabolism—ISYNA1—polycystic ovary syndrome	0.000691	0.00332	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—TH—polycystic ovary syndrome	0.000681	0.00328	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.000672	0.00323	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—PNPLA2—polycystic ovary syndrome	0.000668	0.00321	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—SLC2A4—polycystic ovary syndrome	0.000663	0.00319	CbGpPWpGaD
Zoledronate—CA12—Metabolism—PNPLA2—polycystic ovary syndrome	0.000644	0.0031	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.000639	0.00307	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.000639	0.00307	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—SRD5A1—polycystic ovary syndrome	0.000633	0.00305	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—CYP19A1—polycystic ovary syndrome	0.000623	0.003	CbGpPWpGaD
Zoledronate—CA14—Metabolism—HMMR—polycystic ovary syndrome	0.000616	0.00296	CbGpPWpGaD
Zoledronate—CA12—Metabolism—SRD5A1—polycystic ovary syndrome	0.000611	0.00294	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.000607	0.00292	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—STAR—polycystic ovary syndrome	0.000604	0.00291	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000597	0.00287	CbGpPWpGaD
Zoledronate—CA2—Metabolism—TEAD2—polycystic ovary syndrome	0.000588	0.00283	CbGpPWpGaD
Zoledronate—CA2—Metabolism—AKR1C2—polycystic ovary syndrome	0.000588	0.00283	CbGpPWpGaD
Zoledronate—CA14—Metabolism—HSD3B1—polycystic ovary syndrome	0.000588	0.00283	CbGpPWpGaD
Zoledronate—CA12—Metabolism—STAR—polycystic ovary syndrome	0.000583	0.0028	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—GNAS—polycystic ovary syndrome	0.000556	0.00267	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—HMMR—polycystic ovary syndrome	0.000538	0.00259	CbGpPWpGaD
Zoledronate—CA14—Metabolism—LHB—polycystic ovary syndrome	0.000536	0.00258	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.000535	0.00257	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—NCOR1—polycystic ovary syndrome	0.00053	0.00255	CbGpPWpGaD
Zoledronate—CA14—Metabolism—HSD3B2—polycystic ovary syndrome	0.000524	0.00252	CbGpPWpGaD
Zoledronate—CA12—Metabolism—HMMR—polycystic ovary syndrome	0.000519	0.0025	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—HSD3B1—polycystic ovary syndrome	0.000514	0.00247	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000508	0.00244	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.000507	0.00244	CbGpPWpGaD
Zoledronate—CA14—Metabolism—AKR1C1—polycystic ovary syndrome	0.000507	0.00244	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—CYP1A1—polycystic ovary syndrome	0.000502	0.00242	CbGpPWpGaD
Zoledronate—CA12—Metabolism—HSD3B1—polycystic ovary syndrome	0.000495	0.00238	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PNPLA2—polycystic ovary syndrome	0.000492	0.00237	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.000484	0.00233	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000481	0.00232	CbGpPWpGaD
Zoledronate—ABCC1—Disease—NMNAT3—polycystic ovary syndrome	0.00047	0.00226	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—LHB—polycystic ovary syndrome	0.000468	0.00225	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—MTHFR—polycystic ovary syndrome	0.000468	0.00225	CbGpPWpGaD
Zoledronate—CA14—Metabolism—SULT2A1—polycystic ovary syndrome	0.000467	0.00225	CbGpPWpGaD
Zoledronate—CA2—Metabolism—SRD5A1—polycystic ovary syndrome	0.000467	0.00225	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—HSD3B2—polycystic ovary syndrome	0.000458	0.0022	CbGpPWpGaD
Zoledronate—CA14—Metabolism—RRM2—polycystic ovary syndrome	0.000452	0.00217	CbGpPWpGaD
Zoledronate—CA12—Metabolism—LHB—polycystic ovary syndrome	0.000452	0.00217	CbGpPWpGaD
Zoledronate—CA2—Metabolism—STAR—polycystic ovary syndrome	0.000445	0.00214	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—AKR1C1—polycystic ovary syndrome	0.000443	0.00213	CbGpPWpGaD
Zoledronate—CA12—Metabolism—HSD3B2—polycystic ovary syndrome	0.000441	0.00212	CbGpPWpGaD
Zoledronate—CA14—Metabolism—YAP1—polycystic ovary syndrome	0.000436	0.0021	CbGpPWpGaD
Zoledronate—CA12—Metabolism—AKR1C1—polycystic ovary syndrome	0.000428	0.00206	CbGpPWpGaD
Zoledronate—CA14—Metabolism—NAMPT—polycystic ovary syndrome	0.000419	0.00201	CbGpPWpGaD
Zoledronate—CA14—Metabolism—CYP11A1—polycystic ovary syndrome	0.000414	0.00199	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000412	0.00198	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—SULT2A1—polycystic ovary syndrome	0.000408	0.00196	CbGpPWpGaD
Zoledronate—CA2—Metabolism—HMMR—polycystic ovary syndrome	0.000397	0.00191	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—RRM2—polycystic ovary syndrome	0.000395	0.0019	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—NMNAT3—polycystic ovary syndrome	0.000393	0.00189	CbGpPWpGaD
Zoledronate—CA12—Metabolism—SULT2A1—polycystic ovary syndrome	0.000393	0.00189	CbGpPWpGaD
Zoledronate—CA14—Metabolism—AKR1C3—polycystic ovary syndrome	0.000391	0.00188	CbGpPWpGaD
Zoledronate—CA14—Metabolism—CYP17A1—polycystic ovary syndrome	0.000384	0.00185	CbGpPWpGaD
Zoledronate—CA12—Metabolism—RRM2—polycystic ovary syndrome	0.000381	0.00183	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—YAP1—polycystic ovary syndrome	0.000381	0.00183	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—PPARG—polycystic ovary syndrome	0.00038	0.00183	CbGpPWpGaD
Zoledronate—CA2—Metabolism—HSD3B1—polycystic ovary syndrome	0.000379	0.00182	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000375	0.00181	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—POMC—polycystic ovary syndrome	0.000374	0.0018	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—INS—polycystic ovary syndrome	0.000372	0.00179	CbGpPWpGaD
Zoledronate—CA12—Metabolism—YAP1—polycystic ovary syndrome	0.000367	0.00177	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000367	0.00176	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—NAMPT—polycystic ovary syndrome	0.000366	0.00176	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000364	0.00175	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—CYP11A1—polycystic ovary syndrome	0.000361	0.00174	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—LPCAT2—polycystic ovary syndrome	0.00036	0.00173	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—SUOX—polycystic ovary syndrome	0.00036	0.00173	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000359	0.00173	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000355	0.00171	CbGpPWpGaD
Zoledronate—CA12—Metabolism—NAMPT—polycystic ovary syndrome	0.000353	0.0017	CbGpPWpGaD
Zoledronate—CA12—Metabolism—CYP11A1—polycystic ovary syndrome	0.000349	0.00168	CbGpPWpGaD
Zoledronate—CA2—Metabolism—LHB—polycystic ovary syndrome	0.000345	0.00166	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—AKR1C3—polycystic ovary syndrome	0.000341	0.00164	CbGpPWpGaD
Zoledronate—CA2—Metabolism—HSD3B2—polycystic ovary syndrome	0.000338	0.00162	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—CYP17A1—polycystic ovary syndrome	0.000336	0.00162	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—ISYNA1—polycystic ovary syndrome	0.000335	0.00161	CbGpPWpGaD
Zoledronate—CA14—Metabolism—TH—polycystic ovary syndrome	0.000333	0.0016	CbGpPWpGaD
Zoledronate—CA12—Metabolism—AKR1C3—polycystic ovary syndrome	0.000329	0.00158	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000327	0.00157	CbGpPWpGaD
Zoledronate—CA2—Metabolism—AKR1C1—polycystic ovary syndrome	0.000327	0.00157	CbGpPWpGaD
Zoledronate—CA12—Metabolism—CYP17A1—polycystic ovary syndrome	0.000324	0.00156	CbGpPWpGaD
Zoledronate—CA14—Metabolism—SLC2A4—polycystic ovary syndrome	0.000324	0.00156	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000305	0.00147	CbGpPWpGaD
Zoledronate—CA14—Metabolism—CYP19A1—polycystic ovary syndrome	0.000304	0.00146	CbGpPWpGaD
Zoledronate—CA2—Metabolism—SULT2A1—polycystic ovary syndrome	0.000301	0.00145	CbGpPWpGaD
Zoledronate—CA2—Metabolism—RRM2—polycystic ovary syndrome	0.000291	0.0014	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—TH—polycystic ovary syndrome	0.000291	0.0014	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.00029	0.00139	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—TEAD2—polycystic ovary syndrome	0.000284	0.00137	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—AKR1C2—polycystic ovary syndrome	0.000284	0.00137	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—SLC2A4—polycystic ovary syndrome	0.000283	0.00136	CbGpPWpGaD
Zoledronate—CA2—Metabolism—YAP1—polycystic ovary syndrome	0.000281	0.00135	CbGpPWpGaD
Zoledronate—CA12—Metabolism—TH—polycystic ovary syndrome	0.00028	0.00135	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000274	0.00132	CbGpPWpGaD
Zoledronate—CA12—Metabolism—SLC2A4—polycystic ovary syndrome	0.000273	0.00131	CbGpPWpGaD
Zoledronate—CA14—Metabolism—GNAS—polycystic ovary syndrome	0.000272	0.00131	CbGpPWpGaD
Zoledronate—CA2—Metabolism—NAMPT—polycystic ovary syndrome	0.00027	0.0013	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000269	0.0013	CbGpPWpGaD
Zoledronate—CA2—Metabolism—CYP11A1—polycystic ovary syndrome	0.000266	0.00128	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—CYP19A1—polycystic ovary syndrome	0.000266	0.00128	CbGpPWpGaD
Zoledronate—CA14—Metabolism—NCOR1—polycystic ovary syndrome	0.000259	0.00124	CbGpPWpGaD
Zoledronate—CA12—Metabolism—CYP19A1—polycystic ovary syndrome	0.000256	0.00123	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000253	0.00122	CbGpPWpGaD
Zoledronate—CA2—Metabolism—AKR1C3—polycystic ovary syndrome	0.000252	0.00121	CbGpPWpGaD
Zoledronate—CA2—Metabolism—CYP17A1—polycystic ovary syndrome	0.000248	0.00119	CbGpPWpGaD
Zoledronate—CA14—Metabolism—CYP1A1—polycystic ovary syndrome	0.000245	0.00118	CbGpPWpGaD
Zoledronate—ABCC1—Disease—RPL37A—polycystic ovary syndrome	0.000242	0.00116	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PNPLA2—polycystic ovary syndrome	0.000238	0.00115	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—GNAS—polycystic ovary syndrome	0.000237	0.00114	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000236	0.00113	CbGpPWpGaD
Zoledronate—ABCC1—Disease—HMMR—polycystic ovary syndrome	0.000229	0.0011	CbGpPWpGaD
Zoledronate—CA12—Metabolism—GNAS—polycystic ovary syndrome	0.000229	0.0011	CbGpPWpGaD
Zoledronate—CA14—Metabolism—MTHFR—polycystic ovary syndrome	0.000229	0.0011	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—NCOR1—polycystic ovary syndrome	0.000226	0.00109	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—SRD5A1—polycystic ovary syndrome	0.000226	0.00109	CbGpPWpGaD
Zoledronate—CA12—Metabolism—NCOR1—polycystic ovary syndrome	0.000218	0.00105	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—STAR—polycystic ovary syndrome	0.000216	0.00104	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000216	0.00104	CbGpPWpGaD
Zoledronate—CA2—Metabolism—TH—polycystic ovary syndrome	0.000214	0.00103	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—CYP1A1—polycystic ovary syndrome	0.000214	0.00103	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000213	0.00103	CbGpPWpGaD
Zoledronate—CA2—Metabolism—SLC2A4—polycystic ovary syndrome	0.000209	0.001	CbGpPWpGaD
Zoledronate—CA12—Metabolism—CYP1A1—polycystic ovary syndrome	0.000207	0.000994	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—MTHFR—polycystic ovary syndrome	0.0002	0.000961	CbGpPWpGaD
Zoledronate—CA2—Metabolism—CYP19A1—polycystic ovary syndrome	0.000196	0.000943	CbGpPWpGaD
Zoledronate—CA12—Metabolism—MTHFR—polycystic ovary syndrome	0.000193	0.000927	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—HMMR—polycystic ovary syndrome	0.000192	0.000924	CbGpPWpGaD
Zoledronate—ABCC1—Disease—AKR1C1—polycystic ovary syndrome	0.000189	0.000909	CbGpPWpGaD
Zoledronate—CA14—Metabolism—PPARG—polycystic ovary syndrome	0.000185	0.000892	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—HSD3B1—polycystic ovary syndrome	0.000183	0.000882	CbGpPWpGaD
Zoledronate—CA14—Metabolism—POMC—polycystic ovary syndrome	0.000183	0.00088	CbGpPWpGaD
Zoledronate—CA14—Metabolism—INS—polycystic ovary syndrome	0.000182	0.000875	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000181	0.000872	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000181	0.00087	CbGpPWpGaD
Zoledronate—ABCC1—Disease—FGF18—polycystic ovary syndrome	0.000175	0.000844	CbGpPWpGaD
Zoledronate—CA2—Metabolism—GNAS—polycystic ovary syndrome	0.000175	0.000842	CbGpPWpGaD
Zoledronate—ABCC1—Disease—RBP4—polycystic ovary syndrome	0.000174	0.000836	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000172	0.000826	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—LHB—polycystic ovary syndrome	0.000167	0.000804	CbGpPWpGaD
Zoledronate—CA2—Metabolism—NCOR1—polycystic ovary syndrome	0.000167	0.000802	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—HSD3B2—polycystic ovary syndrome	0.000163	0.000786	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—PPARG—polycystic ovary syndrome	0.000162	0.00078	CbGpPWpGaD
Zoledronate—ABCC1—Disease—GAB1—polycystic ovary syndrome	0.00016	0.00077	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—POMC—polycystic ovary syndrome	0.00016	0.000769	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—INS—polycystic ovary syndrome	0.000159	0.000765	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—AKR1C1—polycystic ovary syndrome	0.000158	0.000761	CbGpPWpGaD
Zoledronate—CA2—Metabolism—CYP1A1—polycystic ovary syndrome	0.000158	0.00076	CbGpPWpGaD
Zoledronate—CA12—Metabolism—PPARG—polycystic ovary syndrome	0.000156	0.000752	CbGpPWpGaD
Zoledronate—ABCC1—Disease—NAMPT—polycystic ovary syndrome	0.000156	0.00075	CbGpPWpGaD
Zoledronate—CA12—Metabolism—POMC—polycystic ovary syndrome	0.000154	0.000741	CbGpPWpGaD
Zoledronate—CA12—Metabolism—INS—polycystic ovary syndrome	0.000153	0.000737	CbGpPWpGaD
Zoledronate—CA2—Metabolism—MTHFR—polycystic ovary syndrome	0.000147	0.000709	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—SULT2A1—polycystic ovary syndrome	0.000146	0.000701	CbGpPWpGaD
Zoledronate—ABCC1—Disease—AKR1C3—polycystic ovary syndrome	0.000145	0.0007	CbGpPWpGaD
Zoledronate—ABCC1—Disease—TNRC6B—polycystic ovary syndrome	0.000143	0.000689	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—RRM2—polycystic ovary syndrome	0.000141	0.000678	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—YAP1—polycystic ovary syndrome	0.000136	0.000654	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—NAMPT—polycystic ovary syndrome	0.000131	0.000628	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.00013	0.000625	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CYP11A1—polycystic ovary syndrome	0.000129	0.000621	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000128	0.000616	CbGpPWpGaD
Zoledronate—ABCC1—Disease—TCF7L2—polycystic ovary syndrome	0.000123	0.00059	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—AKR1C3—polycystic ovary syndrome	0.000122	0.000586	CbGpPWpGaD
Zoledronate—ABCC1—Disease—SLC2A4—polycystic ovary syndrome	0.000121	0.00058	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CYP17A1—polycystic ovary syndrome	0.00012	0.000577	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PPARG—polycystic ovary syndrome	0.000119	0.000575	CbGpPWpGaD
Zoledronate—CA2—Metabolism—POMC—polycystic ovary syndrome	0.000118	0.000567	CbGpPWpGaD
Zoledronate—CA2—Metabolism—INS—polycystic ovary syndrome	0.000117	0.000564	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PRL—polycystic ovary syndrome	0.000115	0.000553	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—TH—polycystic ovary syndrome	0.000104	0.000499	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—SLC2A4—polycystic ovary syndrome	0.000101	0.000486	CbGpPWpGaD
Zoledronate—ABCC1—Disease—NCOR1—polycystic ovary syndrome	9.64e-05	0.000464	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CYP19A1—polycystic ovary syndrome	9.49e-05	0.000457	CbGpPWpGaD
Zoledronate—ABCC1—Disease—NRG1—polycystic ovary syndrome	9.46e-05	0.000455	CbGpPWpGaD
Zoledronate—ABCC1—Disease—MTHFR—polycystic ovary syndrome	8.52e-05	0.00041	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—GNAS—polycystic ovary syndrome	8.47e-05	0.000407	CbGpPWpGaD
Zoledronate—ABCC1—Disease—IRS2—polycystic ovary syndrome	8.1e-05	0.00039	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—NCOR1—polycystic ovary syndrome	8.07e-05	0.000388	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CYP1A1—polycystic ovary syndrome	7.65e-05	0.000368	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—MTHFR—polycystic ovary syndrome	7.13e-05	0.000343	CbGpPWpGaD
Zoledronate—ABCC1—Disease—IRS1—polycystic ovary syndrome	7.07e-05	0.00034	CbGpPWpGaD
Zoledronate—ABCC1—Disease—INS—polycystic ovary syndrome	6.77e-05	0.000326	CbGpPWpGaD
Zoledronate—ABCC1—Disease—AKT2—polycystic ovary syndrome	6.55e-05	0.000315	CbGpPWpGaD
Zoledronate—ABCC1—Disease—SERPINE1—polycystic ovary syndrome	6.22e-05	0.000299	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PPARG—polycystic ovary syndrome	5.78e-05	0.000278	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—POMC—polycystic ovary syndrome	5.7e-05	0.000274	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—INS—polycystic ovary syndrome	5.67e-05	0.000273	CbGpPWpGaD
Zoledronate—ABCC1—Disease—IL6—polycystic ovary syndrome	2.96e-05	0.000142	CbGpPWpGaD
